M&A Deal Summary

Sonic Healthcare Acquires ProPath

On December 17, 2021, Sonic Healthcare acquired healthcare services company ProPath

Acquisition Highlights
  • This is Sonic Healthcare’s 9th transaction in the Healthcare Services sector.
  • This is Sonic Healthcare’s 16th transaction in the United States.
  • This is Sonic Healthcare’s 3rd transaction in Texas.

M&A Deal Summary

Date 2021-12-17
Target ProPath
Sector Healthcare Services
Buyer(s) Sonic Healthcare
Deal Type Add-on Acquisition

Target

ProPath

Dallas, Texas, United States
ProPath is a medically led anatomical pathology (AP) company. ProPath was founded in 1966 and is based in Dallas, Texas.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sonic Healthcare

Sydney, Australia

Category Company
Founded 1934
Sector Medical Products
Employees37,000
Revenue 8.1B AUD (2023)
DESCRIPTION

Sonic Healthcare is a medical diagnostics companies, providing laboratory and radiology services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare was founded in 1934 and is based in Sydney, Australia.


DEAL STATS #
Overall 38 of 43
Sector (Healthcare Services) 9 of 9
Type (Add-on Acquisition) 32 of 35
State (Texas) 3 of 3
Country (United States) 16 of 16
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-17 Canberra Imaging Group

Sydney, Australia

Canberra Imaging Group is a radiology practice in Canberra, Australia’s capital city, with branches also located in Goulburn and Queanbeyan in New South Wales. The practice, with a history going back more than 50 years, employs 15 radiologists and ~200 other staff and operates 10 service sites across 9 locations. CIG operates one fully-funded (via Medicare), two partially-funded and two unlicensed MRI scanners, and also operates one of two private PET CT scanners in Canberra.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-28 Microba Life Sciences

Brisbane City, Australia

Microba Life Sciences is a microbiome company development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Microba Life Sciences was founded in 2018 and is based in Brisbane City, Australia.

Buy -